The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies
- PMID: 36974692
- PMCID: PMC11634123
- DOI: 10.1097/JS9.0000000000000099
The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies
Conflict of interest statement
The authors declare that they have no financial conflict of interest with regard to the content of this report.
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
References
-
- WHO. Circulating vaccine-derived poliovirus type 2 (cVDPV2) – Algeria. 2022. Accessed October 10, 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON406
-
- WHO. Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples–the United Kingdom of Great Britain and Northern Ireland and the United States of America. 2022. Accessed October 10, 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON408
-
- Sah R, Mohanty A, Rohilla R, et al. . Polio outbreak: a longest and ongoing global public health emergency. Travel Med Infect Dis 2022;50:102433. - PubMed
-
- Sultan MA. Emerging challenges to realizing global polio eradication and their solutions. East Mediterr Health J 2022;28:515–520. - PubMed
